Following Dispatch Bio’s recent $216 million capital raise, Brandywine Realty Trust CEO Jerry Sweeney expressed optimism about the region’s life sciences sector, calling it in “recovery mode.” “Green shoots on the capital raising front are emerging,” Sweeney noted, pointing to the funding as a positive indicator amid a challenging market. The milestone is notable given… Read more »
Brandywine Realty Trust’s newly completed 14-story building at 3151 Market St., originally envisioned as a premier life sciences property, may soon welcome office tenants. This possibility emerged after FS Investments signed a 117,000-square-foot lease at Brandywine’s nearby 3025 John F. Kennedy Blvd., bringing that building to 83% occupancy with just over one vacant floor remaining…. Read more »
Vitara Biomedical Inc., a company working on a therapeutic platform to support premature infants, and San Francisco-based Quanta Therapeutics Inc., a biotech focused on therapies for cancer, are among the recent tenants to sign leases at B.Labs, a 50,000-square-foot life sciences incubator at Cira Centre. The leases bring the space to fully occupied. Brandywine Realty… Read more »
